Vina E R, Hannon M J, Quinones C, Hausmann L R M, Ibrahim S A, Dagnino J, Kwoh C K
University of Arizona, Tucson, Arizona.
Pinney Associates, Pittsburgh, Pennsylvania.
ACR Open Rheumatol. 2021 Mar;3(3):154-163. doi: 10.1002/acr2.11235. Epub 2021 Feb 11.
The objective of this study was to evaluate how patient knowledge and beliefs regarding nonsteroidal anti-inflammatory drugs (NSAIDs) may influence the use of NSAIDs for osteoarthritis (OA).
Surveys of 334 adults with knee and/or hip OA were analyzed in this cross-sectional study. Familiarity with and perceptions of benefits/risks of NSAID use were measured to assess associations with the use of prescription and nonprescription oral NSAIDs. Multinomial logistic regression models were adjusted for sociodemographic and clinical variables.
In this sample, 35.9% and 35.6% reported use of oral prescription and nonprescription-only NSAIDs, respectively. Hispanic participants, compared with non-Hispanic White participants, had lower perceived benefit (P = 0.005) and risk (P = 0.001) of prescription NSAIDs. The following were associated with prescription NSAID use instead of no NSAID use: having family/friends who used prescription (relative risk ratio [RRR] 3.91; 95% confidence interval [CI] 2.05-7.47) and over-the-counter (OTC) (RRR 3.10; 95% CI 1.65-5.83) NSAIDs for OA, understanding the consequences of using both prescription (RRR 3.50; 95% CI 1.79-6.86) and OTC (RRR 2.80; 95% CI 1.39-5.65) NSAIDs, higher perceived benefit of both prescription (RRR 2.51; 95% CI 1.71-3.66) and OTC (RRR 1.44; 95% CI 1.01-2.06) NSAIDs, and lower perceived risk of both types of NSAIDs (prescription: RRR 0.63 [95% CI 0.46-0.87]; OTC: RRR 0.53 [95% CI 0.37-0.75]). Similar results were found when we assessed the relationship between these variables and OTC NSAID use versus no oral NSAID use.
Adults with knee and/or hip OA were more likely to use NSAIDs if they were more familiar with, had an increased perceived benefit of, and had a decreased perceived risk of these drugs. Patients' perceptions and beliefs about NSAIDs should be evaluated when considering them for treatment.
本研究的目的是评估患者对非甾体抗炎药(NSAIDs)的知识和信念如何影响NSAIDs在骨关节炎(OA)中的使用。
在这项横断面研究中,对334名患有膝和/或髋OA的成年人进行了调查分析。测量对NSAIDs使用的熟悉程度以及对其益处/风险的认知,以评估与处方和非处方口服NSAIDs使用的相关性。多项逻辑回归模型针对社会人口统计学和临床变量进行了调整。
在该样本中,分别有35.9%和35.6%的人报告使用了口服处方NSAIDs和仅使用非处方NSAIDs。与非西班牙裔白人参与者相比,西班牙裔参与者对处方NSAIDs的感知益处(P = 0.005)和风险(P = 0.001)较低。以下因素与使用处方NSAIDs而非不使用NSAIDs相关:有使用处方(相对风险比[RRR] 3.91;95%置信区间[CI] 2.05 - 7.47)和非处方(OTC)(RRR 3.10;95% CI 1.65 - 5.83)NSAIDs治疗OA的家人/朋友,了解使用处方(RRR 3.50;95% CI 1.79 - 6.86)和OTC(RRR 2.80;95% CI 1.39 - 5.65)NSAIDs的后果,对处方(RRR 2.51;95% CI 1.71 - 3.66)和OTC(RRR 1.44;95% CI 1.01 - 2.06)NSAIDs的更高感知益处,以及对两种类型NSAIDs(处方:RRR 0.63 [95% CI 0.46 - 0.87];OTC:RRR 0.53 [95% CI 0.37 - 0.75])的更低感知风险。当我们评估这些变量与使用OTC NSAIDs而非不使用口服NSAIDs之间的关系时,发现了类似的结果。
患有膝和/或髋OA的成年人如果对这些药物更熟悉、感知益处增加且感知风险降低,则更有可能使用NSAIDs。在考虑将NSAIDs用于治疗时,应评估患者对NSAIDs的认知和信念。